| 01 | Sterile pharmaceutical compounding | Aseptic preparation of injectable medicines and small-batch sterile products | Closed operation with HEPA-filtered supply and exhaust; pressure cascade selected according to product and operator risk | Glove ports, rapid-transfer port, material airlock, integrated weighing area, cleanable stainless-steel interior | Sterility assurance, decontamination cycle validation, ergonomic reach, chamber recovery time, service support | EU GMP Annex 1, ISO 14644 series, applicable national pharmacy and sterile-compounding requirements | Regional GMP expectations, local qualification rules, availability of validated bio-decontamination chemistry |
| 02 | Potent and hazardous drug handling | Antineoplastic drugs, high-potency active pharmaceutical ingredients, and toxic intermediates | Negative-pressure containment with HEPA-filtered exhaust and controlled transfer of materials | Double-door transfer chamber, safe-change filter housing, sealed waste removal, pressure monitoring and alarms | Containment performance, operator exposure control, filter-change safety, cleaning verification, alarm management | NIOSH hazardous-drug guidance, ISO 14644, local occupational-exposure and pharmaceutical GMP requirements | Occupational exposure limits differ by jurisdiction; factory acceptance testing and site containment testing are essential |
| 03 | Cell and gene therapy processing | Cell expansion, viral-vector processing, sample manipulation, and closed aseptic workflows | High-grade clean-air environment with closed processing and validated transfer disinfection | Modular chambers, incubator or centrifuge interfaces, data logging, glove integrity testing, flexible tubing connections | Process scalability, aseptic connectivity, electronic records, cleaning compatibility, validation documentation | EU GMP Annex 1, ISO 14644, applicable advanced-therapy medicinal-product guidance, data-integrity expectations | Different regulatory pathways for clinical and commercial production; local data-integrity and cybersecurity requirements may apply |
| 04 | Microbiology and infectious-disease research | Culture handling, diagnostic research, pathogen studies, and sample inactivation | Personnel and environmental protection based on the biological risk assessment and facility biosafety level | Inward airflow, sealed work zone, exhaust filtration, decontamination connection, interlocked access doors | Validated containment, airflow visualization, microbiological safety, cleanability, emergency operation | WHO Laboratory Biosafety Manual, CDC/NIH BMBL, EN 12469 where applicable, ISO 14644 for clean areas | National biosafety classifications and import/export controls can affect installation, training, and operating procedures |
| 05 | Sterile powder and dry-process isolation | Weighing, blending, sampling, and filling of sterile or dust-sensitive powders | Closed negative-pressure operation with dust control and filtration designed for the powder hazard | Low-turbulence airflow, contained vacuum transfer, split butterfly valve interface, clean-in-place provisions | Powder recovery, cross-contamination control, electrostatic risk, cleaning time, filter loading and maintenance | EU GMP Annex 1, ISO 14644, ATEX or other local explosive-atmosphere requirements where applicable | Electrical classification, dust explosivity data, and hazardous-area certification may vary by country and process |
| 06 | Radiopharmaceutical and nuclear-medicine isolation | Radiotracer preparation, dispensing, quality control, and short-lived isotope workflows | Negative pressure for airborne contamination control combined with shielding and contamination monitoring | Lead or tungsten shielding, shielded transfer systems, remote handling, waste segregation, radiation monitoring interfaces | Shielding calculation, dose reduction, cleanability, isotope compatibility, maintenance access, licensing documentation | IAEA safety guidance, national radiation-protection rules, GMP requirements, ISO 14644 where cleanroom classification applies | Radiation licensing, transport regulations, shielding approval, and qualified medical-physics review are jurisdiction-specific |
| 07 | Animal and veterinary pharmaceutical production | Veterinary injectables, biologics, vaccines, and controlled sample preparation | Aseptic or contained operation selected according to biological, chemical, and cross-contamination risks | Larger work zones, robust surfaces, segregated material routes, flexible transfer ports, washable components | Throughput, cleaning validation, segregation strategy, operator training, utility consumption, expandability | Applicable veterinary GMP, ISO 14644, biosafety guidance, and national animal-health regulations | Registration requirements, cold-chain interfaces, regional veterinary GMP rules, and service coverage influence total cost |
| 08 | Medical-device and diagnostic assembly | Sterile device assembly, reagent filling, diagnostic cartridge production, and microbiological testing | Unidirectional or mixed-flow clean-air protection with controlled personnel and material interfaces | Modular benches, vision-system integration, light curtains, transfer hatches, environmental monitoring ports | Integration with production equipment, repeatability, line clearance, cleanroom classification, automation compatibility | ISO 14644, ISO 13485 quality systems, applicable medical-device regulations, and process-specific cleanliness criteria | Regulatory classification and validation evidence vary by destination market; local electrical and machinery codes may apply |
| 09 | Research and development pilot systems | Formulation development, process optimization, analytical sampling, and scale-up studies | Configurable containment selected for changing materials, batch sizes, and development hazards | Compact footprint, interchangeable glove ports, configurable services, transparent panels, rapid-change tooling | Flexibility, short lead time, modularity, operator comfort, future upgrade path, qualification cost | ISO 14644, applicable biosafety guidance, occupational-hygiene requirements, and site quality procedures | Research funding cycles, import duties, local technical support, and replacement-part availability can affect project timing |
| 10 | Large-scale industrial production | Commercial filling, sterile bulk processing, high-throughput transfer, and multi-stage manufacturing | Fully enclosed production line with validated airflow, automated transfers, and continuous status monitoring | Robotic handling, multiple transfer ports, recipe-controlled operations, CIP/SIP interfaces, redundant monitoring | Throughput, uptime, automation validation, maintainability, utility load, cybersecurity, total cost of ownership | EU GMP Annex 1, ISO 14644, GAMP-oriented computerized-system practices, and applicable machinery and electrical standards | Regional GMP inspection expectations, validation labor, spare-parts logistics, energy costs, and lifecycle service contracts are major cost drivers |